CA9 and neoplasm: By taking advantage of the high binding affinity of aromatic sulfonamide to CAIX, they have been labeled with a variety of radionuclides (i.e., 18F, 64Cu, 68Ga, 99mTc, 111In) and evaluated in preclinical CAIX-positive tumor models.